DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Biogen Idec (NASDAQ: BIIB)

360.67 6.97 (1.97%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $360.67 1.97%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $343.28
Previous Close $353.70
Daily Range $343.06 - $361.93
52-Week Range $270.62 - $361.93
Market Cap $85.2B
P/E Ratio 33.49
Dividend (Yield) $0.00 (0.0%)
Volume 3,690,138
Average Daily Volume 1,778,578
Current FY EPS $13.47

Sector

Healthcare

Industry

Drugs

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary Rss Feed

3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.

Pfizer is a staple in most retirement and income portfolios, but investors can find stronger growth prospects in each of these three big pharmaceutical stocks.

Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog

Integra Lifesciences Up on Launch of Bilayer Skin Product - Analyst Blog

Integra Lifesciences Up on Launch of Bilayer Skin Product - Analyst Blog

Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo

Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half

Biogen Idec (BIIB) Showing Signs Of Perilous Reversal Today

Bruker Unveils bioAFM System for High Resolution Imaging - Analyst Blog

Biogen Idec Poised To Continue Its Stellar Run

Watch For Today's Momo Momentum Stock: Biogen Idec (BIIB)

A 'Wisdom Of Experts' Portfolio

See More BIIB News...

BIIB's Top Competitors

BIIB $360.67 (1.97%)
Current stock: BIIB
AMGN $170.17 (1.00%)
Current stock: AMGN
GILD $108.45 (2.76%)
Current stock: GILD
$0.00 (0.00%)
Current stock: